Search results
Novavax Inc (NVAX) Reports Mixed Q3 Results Amid Cost Reduction Efforts and Vaccine Approvals
GuruFocus.com via Yahoo Finance· 5 months agoNovavax Inc (NASDAQ:NVAX) reported total revenue of $187 million for Q3 2023, a significant decrease...
EMA Panel Endorses Novavax's (NVAX) COVID Jab for Full Approval
Zacks via Yahoo Finance· 11 months agoNovavax's (NVAX) protein-based COVID-19 vaccine gets recommendation for full marketing authorization...
Novavax seeks FDA approval for COVID booster
ABC News via Yahoo News· 2 years agoNovavax has submitted an application to the Food and Drug Administration for Emergency Use Authorization of its COVID-19 vaccine as a booster in adults...
Novavax's (NVAX) COVID-19 Jab Gets Approval in Switzerland
Zacks via Yahoo Finance· 2 years agoNovavax (NVAX) receives expanded temporary authorization for Nuvaxovid, its COVID-19 vaccine, in...
Novavax Stock Is Too Sickly To Buy
InvestorPlace via Yahoo Finance· 2 years agoNovavax’s Covid-19 vaccine still isn’t approved for use in the U.S. With the pandemic in full retreat and the majority of people now fully vaccinated,...
Novavax Covid vaccine becomes fourth to receive FDA approval
The Independent via Yahoo News· 2 years agoThe Food and Drug Administration authorised the use of Novavax Covid-19 vaccine for adults on...
Novavax's COVID-19 Vaccine Gets Back To Back Approval In Japan, Australia For Adolescents
Benzinga via Yahoo Finance· 2 years agoNovavax Inc's (NASDAQ: NVAX) Nuvaxovid (NVX-CoV2373) COVID-19 vaccine received expanded...
Novavax Covid Vaccine Could Soon Win EUA Approval — And So What?
TipRanks via Yahoo Finance· 2 years agoAt long last, Novavax (NVAX) may be close to getting its EUA. As the company announced late Tuesday,...
Novavax (NVAX) to Report Q2 Earnings: What's in the Cards?
Zacks via Yahoo Finance· 2 years agoWe expect investors to focus on the sales performance of Novavax’s NVAX protein-based COVID-19...
Novavax Stock Looks Like a Good Value With Its New Combined Vaccine
InvestorPlace via Yahoo Finance· 2 years agoNovavax (NVAX) is down from a peak of $217.32 on Dec. 17 to just $53.69, reaching a new low. The...
